Search results
Our mission is to cure complex brain diseases. We are reinventing neuro drug discovery by combining human brain models, scaled biology and machine learning to systematically discover and develop novel drugs with greater therapeutic potential. Cures, not correlations.
- Our Approach
Herophilus is reinventing neuro drug discovery by combining...
- Pipeline
Pipeline. Our systematic approach to therapeutics discovery...
- News
Herophilus was an Alexandrian physician (circa 300 BC) who...
- Publications
Publications. The team of scientists at Herophilus develops...
- Reading
See what the Herophilus team is reading this week across the...
- Careers
The pharmaceutical industry has been largely unsuccessful at...
- Our Approach
Herophilus is reinventing neuro drug discovery by combining human brain models, scaled biology and machine learning to systematically discover and develop novel drugs with greater therapeutic potential for complex brain diseases.
Apr 20, 2023 · San Francisco-based Herophilus created organoids to model the rare disorder Rett syndrome and used them to screen for compounds that turn on a gene that is silenced in patients with the neurological condition, said co-founder and Chief Executive Saul Kato.
Herophilus is a San Francisco based neurotherapeutics development company that employs AI-driven phenotypic screening to discover and develop novel drugs for complex brain diseases,...
Sep 11, 2023 · Herophilus, a leading biotechnology company with the mission to discover neurotherapeutics to cure complex brain diseases, today announced that Genent.
Sep 11, 2023 · SAN FRANCISCO, September 11, 2023--Herophilus, a leading biotechnology company with the mission to discover neurotherapeutics to cure complex brain diseases, today announced that Genentech, a...
People also ask
Who is Herophilus?
How is Herophilus reinventing neuro drug discovery?
What did Herophilus focus his studies on?
Does Herophilus have a neurotherapeutic research program?
Sep 12, 2023 · Explore Genentech’s acquisition of Herophilus, innovators in the next-generation drug discovery platform. Uncover how this move will impact neurodegeneration research, broaden neuroscience innovation, and boost disease-modifying therapies.